NYSE:MTNB | Cash Flow Statement | Matinas BioPharma Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2013-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.33M
2026-03-31-$1.92M-$1.6M
2025-12-31-$1.91M$3,000.00-$1.51M$15,000.00$58,000.00
2025-09-30-$1.53M
2025-06-30-$5.25M
2025-03-31-$1.66M$18,000.00-$2.01M$1.65M
2024-12-31-$8.43M$90,000.00-$3.51M$500,000.00-$1,000.00
2024-09-30-$4.28M
2024-06-30-$5.72M
2024-03-31-$5.82M$94,000.00-$5.77M$2M$53,000.00
2023-12-31-$5.31M$97,000.00-$4.58M$0.00$2.96M-$1,000.00
2023-09-30-$6.06M
2023-06-30-$6.06M
2023-03-31-$5.51M$93,000.00-$4.09M$3M-$4,000.00
2022-12-31-$3.63M$92,976.00-$4.3M$42,000.00-$42,000.00-$5,000.00
2022-09-30-$5.46M
2022-06-30-$5.92M
2022-03-31-$5.98M$69,000.00-$4.76M$545,000.00$2.96M$93,000.00
2021-12-31-$6.7M$64,579.00-$3.96M$35,812.00$56,653.00$8,330.00
2021-09-30-$6.84M$224,000.00
2021-06-30-$4.79M
2021-03-31-$4.96M$58,647.00-$4.65M$8.82M$6.78M
2020-12-31-$6.34M$57,812.00-$4.31M$0.00$9.09M$549,567.00
2020-09-30-$5.45M$0.00
2020-06-30-$5.61M
2020-03-31-$5.05M$57,622.00-$4.66M$5,749.00-$54.97M$47.44M
2019-12-31-$5.57M$57,046.00-$4.9M$0.00-$5.61M$10,287.00
2019-09-30-$4.4M
2019-06-30-$3.34M
2019-03-31-$4.05M$47,867.00-$3.02M$14,246.00-$14,246.00$30.03M
2018-12-31-$3.63M$61,743.00-$2.62M$0.00$0.00$8.36M
2018-09-30-$2.94M
2018-06-30-$3.41M
2018-03-31-$4.11M$47,138.00-$2.81M$101,916.00-$101,916.00-$135,691.00
2017-12-31-$3.63M$44,376.00-$1.92M$118,294.00-$118,294.00$339,366.00
2017-09-30-$3.39M
2017-06-30-$3.97M$12,000.00
2017-03-31-$4.5M$11,986.00-$3.03M$14.76M
2016-12-31-$1.89M$12,679.00-$2.12M$0.00$1,809.00
2016-09-30-$1.84M
2016-06-30-$1.62M$13,000.00
2016-03-31-$2.24M$12,891.00-$1.54M$0.00
2015-12-31-$2.01M$10,844.00-$1.12M$22,932.00
2015-09-30-$2.15M
2015-06-30-$2.4M
2015-03-31-$2.57M$10,856.00-$2.32M$4,845.00
2014-12-31-$3.04M-$9,914.00-$2.42M$1.00
2014-09-30-$2.61M
2014-06-30-$2.43M
2014-03-31-$2.14M-$2.09M$193,277.00
2013-12-31-$1.8M-$1.67M$65,890.00
2013-09-30-$1.46M
2013-06-30-$343,314.00
2013-03-31-$112,133.00-$150,123.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$10.35M$32,000.00-$7.01M$335,000.00$3.39M
2024-12-31-$24.25M$365,000.00-$15.89M$9.21M$9.17M
2023-12-31-$22.94M$385,000.00-$15.28M$218,000.00$13.24M-$7,000.00
2022-12-31-$21M$337,000.00-$19.16M$892,000.00$4.88M$79,000.00
2021-12-31-$23.28M$244,000.00-$15.22M$260,000.00$16.77M$6.97M
2020-12-31-$22.45M$231,058.00-$17.37M$5,749.00-$40.67M$48.05M
2019-12-31-$17.37M$205,964.00-$14.09M$405,604.00-$6.01M$29.85M
2018-12-31-$14.08M$218,308.00-$10.32M$535,916.00-$535,916.00$15.87M
2017-12-31-$15.49M$100,605.00-$11.46M$942,180.00-$942,180.00$15.6M
2016-12-31-$7.6M$52,644.00-$6.12M$0.00$7M
2015-12-31-$9.14M$43,502.00-$7.81M$76,179.00-$5,425.00$8.46M
2014-12-31-$10.22M$41,581.00-$7.96M$288,519.00
2013-12-31-$3.71M-$2.99M$94,188.00